Eledon Pharmaceuticals, Inc. (ELDN) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$9.65M2013: -$15.72M2014: -$23.30M2015: -$45.09M2016: -$5.66M2017: -$13.12M2018: -$14.06M2019: -$16.01M2020: -$22.81M2021: -$34.51M2022: -$87.97M2023: -$116.54M2024: -$36.18M2025: -$45.62M-$45.62M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$45.62M-26.1%
2024-$36.18M+69.0%
2023-$116.54M-32.5%
2022-$87.97M-154.9%
2021-$34.51M-51.3%
2020-$22.81M-42.5%
2019-$16.01M-13.8%
2018-$14.06M-7.2%
2017-$13.12M-131.9%
2016-$5.66M+87.5%
2015-$45.09M-93.5%
2014-$23.30M-48.1%
2013-$15.72M-63.0%
2012-$9.65M